(lp0
S'NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for ... Business Wire  - Mar 13, 2017 FORT MYERS, Fla.----NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics solutions from biomarker discovery to meaningful diagnostics, today&nbsp;...BRIEF-NeoGenomics and Definiens to develop novel assays for clinical trials ... - Reuters'
p1
aS'Moving Average Crossover Alert: NeoGenomics  Nasdaq - 18 hours ago NeoGenomics, Inc.NEO could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.'
p2
aS'Why Neogenomics Inc is Soaring Higher Today Motley Fool - Oct 21, 2015 What: Shares of Neogenomics , a cancer-focused provider of genetic and molecular testing services for hospitals, pathologists, and oncologists, were up more than 20% in trading today after the company announced that it is acquiring Clarient ...NeoGenomics to Acquire GE Cancer Testing Unit Clarient - Wall Street JournalForm 8-K NEOGENOMICS INC For: Oct 21 - StreetInsider.com'
p3
aS'NeoGenomics Completes Acquisition of Clarient, Inc. PR Newswire  - Dec 30, 2015 30, 2015 /PRNewswire/ -- NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of Clarient, Inc. and its wholly-owned subsidiary Clarient Diagnostic ...NeoGenomics acquires Clarient and Clarient Diagnostic Services - News-Medical.net'
p4
aS'NeoGenomics Inc.  Moves Lower on Volume Spike for March 13 Equities.com - Mar 13, 2017 NeoGenomics Inc.  traded on unusually high volume on Mar. 13, as the stock lost 0.63% to close at $7.91. On the day, NeoGenomics Inc. saw 536,742 shares trade hands on 1,807 trades. Considering that the stock averages only a daily volume of&nbsp;...'
p5
aS'NeoGenomics signs Definitive Agreement to acquire Clarient, Inc. PR Newswire  - Oct 21, 2015 FORT MYERS, Fla., Oct. 21, 2015 /PRNewswire/ -- NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services, announced today that it has reached an agreement to acquire Clarient, Inc., and its wholly-owned&nbsp;...'
p6
aS'Stock Returns: Enzo Biochem Inc  is Beating NeoGenomics Inc  CML News - 19 hours ago This is a snapshot to compare the stock returns for Enzo Biochem Inc  versus NeoGenomics Inc  . The stock return points we compare look at the last three-months, six-months and twelve-months.'
p7
aS"BRIEF-Neogenomics Inc, some units and Neogenomics Laboratories enter credit ... Reuters - Dec 27, 2016 Feb 12 Kuwait's central bank released the following December money supply and bank lending data on Sunday, showing annual bank loan growth at its slowest since January 2012."
p8
aS'NeoGenomics reports Q4 and FY16 results; updates guidance Seeking Alpha - Feb 22, 2017 NeoGenomics  Q4 results: Revenues: $60.5M ; Operating Loss:  ; Net Loss: ; Loss Per Share: ; Non-GAAP EPS: $0.05 .NeoGenomics Inc.  Moves Lower on Volume Spike for February 21 - Equities.comNeoGenomics reports 4Q loss - Yahoo Finance'
p9
aS'NeoGenomics, Inc.  Given a $11.00 Price Target at Cantor Fitzgerald Chaffey Breeze - Mar 14, 2017 NeoGenomics, Inc. logo Cantor Fitzgerald set a $11.00 target price on NeoGenomics, Inc.  in a report issued on Monday morning.'
p10
a.